VERSAJECT Trademark

Trademark Overview


On Wednesday, March 15, 2023, a trademark application was filed for VERSAJECT with the United States Patent and Trademark Office. The USPTO has given the VERSAJECT trademark a serial number of 97841416. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, December 18, 2023. This trademark is owned by Nspire Medical Technologies, LLC. The VERSAJECT trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus, namely, infusion and injection devices for administering drugs
versaject

General Information


Serial Number97841416
Word MarkVERSAJECT
Filing DateWednesday, March 15, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkVERSA INJECT
Goods and ServicesMedical apparatus, namely, infusion and injection devices for administering drugs

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 6, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNspire Medical Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAthens, TX 75752

Trademark Events


Event DateEvent Description
Monday, December 18, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 18, 2023LETTER OF SUSPENSION E-MAILED
Monday, December 18, 2023SUSPENSION LETTER WRITTEN
Tuesday, December 12, 2023ASSIGNED TO EXAMINER
Thursday, April 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 18, 2023NEW APPLICATION ENTERED